Syrian Arab Republic vs Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

Syrian Arab Republic
2.9%
in 2024
Timor-Leste
1.0%
in 2024
Syrian Arab Republic rank
1st
Timor-Leste rank
3rd

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • Syrian Arab Republic
  • Timor-Leste
1234201520192024

How they compare

Syrian Arab Republic currently reports 2.9% against 1.0% in Timor-Leste, a difference of 1.9%.

That makes Syrian Arab Republic's figure about 2.9 times Timor-Leste's.

The two have swapped places 1 time across 10 shared years of data; in 2015 it was Timor-Leste ahead.

Syrian Arab Republic ranks 1st and Timor-Leste ranks 3rd of 15 groups.

Syrian Arab Republic has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Syrian Arab Republic Timor-Leste Difference Ahead
2010s 3.5% 2.5% 1.0% Syrian Arab Republic
2020s 3.4% 1.3% 2.0% Syrian Arab Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Syrian Arab Republic or Timor-Leste?
Syrian Arab Republic, at 2.9% against 1.0% in Timor-Leste as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Syrian Arab Republic and Timor-Leste?
1.9%, with Syrian Arab Republic ahead.
How many years of comparable data are there for Syrian Arab Republic and Timor-Leste?
10 years are reported by both, from 2015 to 2024.
How do Syrian Arab Republic and Timor-Leste rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Syrian Arab Republic ranks 1st and Timor-Leste ranks 3rd of 15 groups.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Syrian Arab Republic vs Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 04 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/syrian-arab-republic-2/timor-leste-2/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/syrian-arab-republic-2/timor-leste-2/">Syrian Arab Republic vs Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
236 places, 2,360 data points, 2015–2024
Last refreshed